ALY688 ophthalmic solution

ALY688 · Allysta Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALY688 ophthalmic solution, covering 2023-06-22 to 2023-06-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 1, Phase 2]